| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
48,937 |
36,920 |
$7.72M |
| H2020 |
Therapeutic behavioral services, per diem |
8,223 |
4,149 |
$1.28M |
| 3074F |
|
16,070 |
13,116 |
$503.66 |
| 0001A |
|
386 |
101 |
$494.96 |
| 3078F |
|
14,161 |
11,606 |
$443.66 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,177 |
22,798 |
$256.14 |
| 0002A |
|
144 |
46 |
$247.48 |
| 3079F |
|
5,301 |
4,509 |
$215.00 |
| 3044F |
|
165 |
141 |
$100.00 |
| 3075F |
|
2,285 |
1,963 |
$75.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,457 |
6,204 |
$31.64 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,916 |
2,877 |
$22.62 |
| 99000 |
|
617 |
217 |
$20.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
874 |
716 |
$16.93 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
891 |
783 |
$7.68 |
| 3077F |
|
844 |
713 |
$5.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,166 |
1,014 |
$0.21 |
| 90834 |
Psychotherapy, 45 minutes with patient |
5,258 |
2,559 |
$0.01 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
614 |
464 |
$0.00 |
| 1036F |
|
16,283 |
12,913 |
$0.00 |
| 87428 |
|
613 |
407 |
$0.00 |
| 3080F |
|
197 |
179 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,411 |
3,730 |
$0.00 |
| 3008F |
|
19,589 |
15,629 |
$0.00 |
| 1034F |
|
2,836 |
2,382 |
$0.00 |
| 96127 |
|
589 |
475 |
$0.00 |
| 92551 |
|
2,724 |
2,300 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
548 |
416 |
$0.00 |
| 90686 |
|
20 |
20 |
$0.00 |
| 87430 |
|
790 |
584 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
35 |
28 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
61 |
57 |
$0.00 |
| 87807 |
|
127 |
93 |
$0.00 |
| 90698 |
|
205 |
177 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
67 |
53 |
$0.00 |
| 85018 |
|
106 |
95 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
238 |
85 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
13 |
$0.00 |
| 99406 |
|
34 |
27 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
16 |
16 |
$0.00 |
| 99173 |
|
2,813 |
2,337 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
221 |
196 |
$0.00 |
| 87400 |
|
957 |
692 |
$0.00 |
| 1159F |
|
17,439 |
13,869 |
$0.00 |
| 1160F |
|
17,625 |
14,032 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,349 |
1,709 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
204 |
143 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,031 |
788 |
$0.00 |
| 90682 |
|
140 |
128 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
630 |
407 |
$0.00 |
| 90670 |
|
255 |
222 |
$0.00 |
| 91300 |
|
759 |
224 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
759 |
658 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
220 |
138 |
$0.00 |
| 90734 |
|
107 |
97 |
$0.00 |
| 90633 |
|
88 |
80 |
$0.00 |
| 80305 |
|
81 |
67 |
$0.00 |
| 3725F |
|
106 |
99 |
$0.00 |
| 81003 |
|
31 |
24 |
$0.00 |
| 90710 |
|
51 |
42 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
15 |
12 |
$0.00 |